A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Epstein-Barr Virus Early Antigen Ab, IgG
MessageSendout, Mayo test code: EAEBV
Test Code
LAB654
Alias/See Also
EBV IgG Antibody to Early Antigen
E. B. Virus (Early Antigen)
EA (Early Antigen)
Early Antigen EBV EARLY AG(S)
Epstein Barr Virus Early Ag Ab
Epstein-Barr Virus (EBV) Early Antigen
EBVE
EAEBV
E. B. Virus (Early Antigen)
EA (Early Antigen)
Early Antigen EBV EARLY AG(S)
Epstein Barr Virus Early Ag Ab
Epstein-Barr Virus (EBV) Early Antigen
EBVE
EAEBV
CPT Codes
86663
Preferred Specimen
1 mL serum from a gold serum gel tube
Minimum Volume
0.4 mL
Other Acceptable Specimens
Red tube
Instructions
Centrifuge and aliquot serum into a plastic vial.
Transport Container
Plastic vial
Transport Temperature
Refrigerated
Specimen Stability
Refrigerated (preferred): 14 days
Frozen: 14 days
Frozen: 14 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis: Reject
Gross lipemia: Reject
Heat-activated specimen: Reject
Gross lipemia: Reject
Heat-activated specimen: Reject
Methodology
Enzyme-Linked Immunosorbent Assay (ELISA)
FDA Status
Approved
Setup Schedule
Monday through Friday
Report Available
1-3 days
Limitations
This test detects both restricted (R) and diffuse (D) forms the Epstein Barr virus (EBV) early antigen. The test system is not designed to differentiate between antibodies to the R and D components.
False negative results may occur in immunosuppressed patients.
The performance characteristics of this assay have not been established for Burkitt’s Lymphoma, nasopharyngeal carcinoma, and lymphoproliferative disorders.
The performance has been established for the aid in the diagnosis of EBV-associated infectious mononucleosis.
False negative results may occur in immunosuppressed patients.
The performance characteristics of this assay have not been established for Burkitt’s Lymphoma, nasopharyngeal carcinoma, and lymphoproliferative disorders.
The performance has been established for the aid in the diagnosis of EBV-associated infectious mononucleosis.
Reference Range
Included with report
Clinical Significance
Diagnosis of Epstein Barr virus (EBV) infectious mononucleosis in cases when heterophile antibody test results are negative and EBV-specific serologic testing is inconclusive
Aiding in the diagnosis of type 2 or type 3 nasopharyngeal carcinoma (NPC)
This test is not useful for screening patients for NPC.
Aiding in the diagnosis of type 2 or type 3 nasopharyngeal carcinoma (NPC)
This test is not useful for screening patients for NPC.
Performing Laboratory
Mayo Clinic Laboratories, Rochester, Minnesota
Additional Information
Epstein-Barr Virus Early Antigen, IgG, Serum